McDermott was a gold sponsor of IPBC Global 2019, at which Edward. A Gordon moderated a panel at on the topic of “Innovative IP Strategies for Life Sciences.”

The panel discussed critical IP topics for pharmaceutical and biotech companies, including managing pharmaceutical IP in the age of big data and personalized medicine, learning lessons from the high-tech sector and a new focus on monetization – CRISPR and beyond.

For more information please click here.